China’s Kelun Expects ADC Strategy To Deliver By Balancing Safety, Efficacy

Major Merck Deals

 
• By Dexter Jie Yan
drug design rationale
Kelun says ADC programs at center of Merck deals balance safety and efficacy. • Source: Shutterstock

More from China

More from Focus On Asia